Peripheral Arterial Disease: An Underestimated Aspect of
Menopause-related Cardiovascular Disease

Panagiotis      Anagnostis; Dimitri   P.   Mikhailidis; Ales      Blinc; Mojca      Jensterle; Mateja   K.   Ježovnik; Gerit-Holger      Schernthaner; Pier   Luigi   Antignani; Katica   Bajuk   Studen; Miso      Sabovic; Pavel      Poredos

« Previous Next »

Download Options

Rights & Permissions Print Cite

Current Vascular Pharmacology

Title:Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease

Volume: 22 Issue: 2

Author(s): Panagiotis Anagnostis*, Dimitri P. Mikhailidis, Ales Blinc, Mojca Jensterle, Mateja K. Ježovnik, Gerit-Holger Schernthaner, Pier Luigi Antignani, Katica Bajuk Studen, Miso Sabovic and Pavel Poredos

Affiliation:

Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Anagnostis Panagiotis*, Mikhailidis P. Dimitri, Blinc Ales, Jensterle Mojca, Ježovnik K. Mateja, Schernthaner Gerit-Holger, Antignani Luigi Pier, Studen Bajuk Katica, Sabovic Miso and Poredos Pavel, Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease, Current Vascular Pharmacology 2024; 22 (2) . https://dx.doi.org/10.2174/0115701611295374231212110458

DOI https://dx.doi.org/10.2174/0115701611295374231212110458	Print ISSN 1570-1611
Publisher Name Bentham Science Publisher	Online ISSN 1875-6212

About this journal

Call for Papers in Thematic Issues

Submission closes on : 22 October, 2024

Advancements in Arterial Stiffness: Novel Therapeutic Frontiers

Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more

Guest Editor(s): Dr. Iv?n Cavero-Redondo

Submission closes on : 07 May, 2024

Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy

Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more

Guest Editor(s): Dr. William Matsui

Submission closes on : 31 January, 2025

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more

Guest Editor(s): Dr. Stefanos Roumeliotis